NCT01036893View on ClinicalTrials.gov

M0001 Effects on Oral Contraceptive Plasma Levels

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

May 31, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

prucalopride

prucalopride 2 mg oral dosing o.d. for 6 days

Trial Locations (1)

D-41460

FOCUS GmbH, Neuss

Sponsors

Lead Sponsor

Movetis
All Listed Sponsors
collaborator

FOCUS GmbH

UNKNOWN

lead

Movetis

INDUSTRY